AI Discovers Two Distinct Prostate Cancer Subtypes

A groundbreaking study using artificial intelligence has identified two distinct subtypes of prostate cancer, paving the way for more personalized treatment approaches.

Researchers have identified two distinct subtypes of prostate cancer, potentially leading to more personalized treatments.
The study, involving AI analysis of DNA from 159 patients, could revolutionize how prostate cancer is diagnosed and treated.
Findings suggest that these subtypes, or 'evotypes,' could help predict the aggressiveness of the cancer and guide treatment decisions.
The discovery was made by an international consortium of researchers, including teams from the University of Oxford and the University of Manchester.
Experts hope the study will not only improve prostate cancer treatment but also aid in understanding other types of cancer.